​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

  • The next meeting of the Prescription Drug Affordability Board will take place on November 25, 2024. More information can be found here​.
  • NOTICE: COMAR 14.01.04 Cost Review Study Process,​Emergency Action- The Prescription Drug Affordability Board seeks emergency action on proposed amendments to .05 under COMAR 14.01.04 Cost Review Study Process.  The text of the proposed amendments is available here​. ​

  • NOTICE OF PROPOSED ACTION:
    COMAR 14.01.04 Cost Review Study Process
    The Maryland Prescription Drug Affordability Board proposes to amend Regulation .05 under COMAR 14.01.04 Cost Review Study Process. The text of the proposed amendments are available in the November 1, 2024 version of the Maryland register located here
    Please visit the regulations page​ for more information including how to submit comments. Comments are due December 2, 2024.


Join the Prescription Drug Affordability Board's Mailing List
Please  follow the instructions to register for the PDAB's Mailing List. This will allow you to keep up to date on the actions of the PDAB.​

Section2

Section3

Section5